Unresectable locally advanced/advanced non-small cell lung cancer
Conditions
Interventions
Experimental Group:None
Sponsors
HenanCancerHospital
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1.The subjects voluntarily participated in this study and signed the informed consent form; 2.Advanced NSCLC confirmed by histological or cytological examination, with no mutations in the driver genes; 3.NSCLC patients were enrolled before receiving only 4-6 cycles of chemotherapy or immunotherapy combined with chemotherapy (advanced stage); 4.They were willing and able to undergo follow-up until death, the end of the study, or the termination of the study;
Exclusion criteria
Exclusion criteria: 1.Patients who do not meet the inclusion criteria or lack legal capacity or have restricted legal capacity;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival;Safety; | — |
Countries
China
Contacts
Public ContactLiu Jie
HenanCancerHospital
Outcome results
None listed